![Show Menu](styles/mobile-menu.png)
![Page Background](./../common/page-substrates/page0897.jpg)
50% of patients
with NSCLC
did not receive
treatment according to
the well
accepted guidelines
EBM is based on selected series
of patients and is
not applicable
to
an average patient in clinical practice
Stage III
NSCLC:
the gap
between an ideal patient from the guidelines
and the average patient from clinical practice
is especially wide
Vast
majority
of patients present
bulky tumors
and/or suffer from
significant
comorbidity
Zwitter M.
J Thorac Oncol.
2012;7